<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01248663</url>
  </required_header>
  <id_info>
    <org_study_id>2006-020</org_study_id>
    <nct_id>NCT01248663</nct_id>
  </id_info>
  <brief_title>Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery</brief_title>
  <official_title>Influence of the Reconstruction Method on the Incidence of Delayed Gastric Emptying After Pylorus Preserving Pancreaticoduodenectomy. A Prospective, Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreaticoduodenectomy (whipple procedure) is the standard operation for tumors of the&#xD;
      pancreatic head, uncinate process, distal common bile duct as well as the papilla of vater.&#xD;
      For reconstruction, pylorus-preservation (PPPD) has been shown to be technically and&#xD;
      oncologically equivalent to the traditional whipple operation. One issue with this technique&#xD;
      is delayed gastric emptying (DGE), which occurs in 25-70% of patients, usually emerging&#xD;
      between day 4 and 14 after surgery. Patients with severe DGE can not only experience&#xD;
      prolonged length of hospital stay, but are also at increased risk for other complications&#xD;
      like aspiration or other issues related to the inability to ingest nutrition.&#xD;
&#xD;
      There is vast retrospective evidence and one prospective study indicating that antecolic&#xD;
      reconstruction of the duodenojejunostomy can improve the rate and severity of delayed gastric&#xD;
      emptying.&#xD;
&#xD;
      The investigators have conducted a prospective randomized trial in order to test this&#xD;
      hypothesis. Patients were randomized to either undergo antecolic or retrocolic reconstruction&#xD;
      after PPPD. On day 10 after surgery, DGE was assessed by clinical criteria. In addition, a&#xD;
      test meal including 1g paracetamol was administered to check for clinically inapparent DGE.&#xD;
      Of these serum samples, kinetics of intestinal peptides like GLP-1, PYY and glucagon was alos&#xD;
      measured.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delayed gastric emptying</measure>
    <time_frame>Postoperative day 10</time_frame>
    <description>Gastric emptying will be assessed by clinical criteria on postoperative day 10 after pylorus-preserving pancreatico-duodenectomy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Paracetamol reabsorption test</measure>
    <time_frame>postoperative day 10</time_frame>
    <description>On day 10 after pylorus-preserving pancreaticoduodenectomy, a test meal of a commercially available dietary product (Fresubin protein energy(c)) and 1g paracetamol will be administered. Serum levels of paracetamol will be measured at 0, 15, 30, 60 and 90 minutes after administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of plasma intestinal peptides</measure>
    <time_frame>postoperative day 10</time_frame>
    <description>On day 10 after pylorus-preserving pancreaticoduodenectomy, a test meal of a commercially available dietary product (Fresubin protein energy(c)) and 1g paracetamol will be administered. Serum levels of glucagon-like peptide-1 (GLP-1), peptide YY (PYY) and Glucagon will be measured at 0, 15, 30, 60 and 90 minutes after administration.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Pancreatic Cancer</condition>
  <condition>Surgery</condition>
  <condition>Improvement of Perioperative Outcome</condition>
  <arm_group>
    <arm_group_label>antecolic reconstruction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After completion of pancreaticoduodenectomy and reconstruction of the pancreaticojejunostomy and hepaticojejunostomy, the reconstruction of the intestinal passage will be conducted by performing an antecolic duodeno-jejunostomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>retrocolic reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After completion of pancreaticoduodenectomy and reconstruction of the pancreaticojejunostomy and hepaticojejunostomy, the reconstruction of the intestinal passage will be conducted by performing a retrocolic duodeno-jejunostomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>antecolic reconstruction</intervention_name>
    <description>see study arm description</description>
    <arm_group_label>antecolic reconstruction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>retrocolic reconstruction</intervention_name>
    <description>see study arm description</description>
    <arm_group_label>retrocolic reconstruction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  verified cancer of the pancreatic head/neck/uncinate process or distal bile duct,&#xD;
             radiographically suspicious tumor requiring pancreaticoduodenectomy&#xD;
&#xD;
          -  pylorus-preserving reconstruction planned&#xD;
&#xD;
          -  no evidence of distant metastases&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt;18 or &gt;90 years&#xD;
&#xD;
          -  status post surgical resection of stomach or duodenum&#xD;
&#xD;
          -  locally unresectable:&#xD;
&#xD;
          -  invasion of the hepatic artery/superior mesenteric artery&#xD;
&#xD;
          -  &gt;180 deg invasion of portal vein/superior mesenteric vein&#xD;
&#xD;
          -  gastric invasion&#xD;
&#xD;
          -  hypersensitivity to paracetamol&#xD;
&#xD;
          -  clinically significant anastomotic dehiscence&#xD;
&#xD;
          -  postoperative pancreatitis &gt; day 10&#xD;
&#xD;
          -  preoperative evidence of gastroparesis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Gnant, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2007</verification_date>
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2010</study_first_posted>
  <last_update_submitted>November 24, 2010</last_update_submitted>
  <last_update_submitted_qc>November 24, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Michael Gnant</name_title>
    <organization>Medical University of Vienna</organization>
  </responsible_party>
  <keyword>pancreatic cancer</keyword>
  <keyword>pylorus-preserving pancreaticoduodenectomy</keyword>
  <keyword>delayed gastric emptying</keyword>
  <keyword>reconstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

